ElderTech go-to-market is uniquely complex — three distinct buyer segments, emerging category awareness, and institutional procurement requirements. We build GTM strategies that sequence these challenges correctly so you build momentum instead of spinning wheels.

The Problem

Three buyer segments, zero repeatable sales process

Your product could be sold to older adults directly, to family caregivers, or to institutions like health systems and senior living operators. Each segment has different discovery channels, decision criteria, price sensitivity, and sales cycles. Most eldertech companies try all three simultaneously and fail to build a repeatable process in any of them. The result is scattered effort and inconsistent revenue.

The category doesn't exist in your buyers' minds yet

When your buyer doesn't know your product category exists, every sales conversation starts with education, not evaluation. This extends sales cycles dramatically and makes traditional demand gen tactics less effective. You're not competing against other eldertech companies for market share — you're competing against inertia and the status quo. Your GTM needs to account for the education burden.

Consumer acquisition economics don't work without institutional validation

Direct-to-consumer eldertech has brutal unit economics. Older adults are expensive to reach through digital channels, conversion rates are low because trust barriers are high, and price sensitivity limits what you can charge. Many eldertech companies discover that the path to consumer scale actually runs through institutional partnerships — health systems, insurers, and senior living operators who can deploy the product to their populations.

Your sales team can't navigate healthcare procurement

If institutional sales is part of your GTM, you need people and processes designed for healthcare buying cycles. These involve clinical evaluation committees, IT security reviews, compliance assessments, legal contract negotiations, and multi-month timelines. Startup sales reps who've only sold to SMBs or consumers are not equipped for this. The GTM strategy needs to account for the resources and time these cycles require.

How We Help

We start by helping you make the hardest GTM decision in eldertech: which buyer segment to lead with. This isn't about choosing one forever — it's about choosing one first so you can build traction, case studies, and revenue before expanding. We analyze your current pipeline, product capabilities, competitive position, and unit economics to make this decision with data, not gut feel.

Once the lead segment is defined, we build the GTM motion for that segment specifically. For consumer/caregiver-led strategies, this means defining acquisition channels, building the conversion funnel, establishing trust signals, and designing the onboarding experience. For institutional-led strategies, this means identifying target accounts, building the enterprise sales toolkit, designing the pilot program framework, and creating the clinical evidence package buyers need.

Positioning and messaging are calibrated to the lead segment. If you're going institutional first, your messaging emphasizes outcomes data, compliance, and operational efficiency. If you're going consumer first, your messaging emphasizes independence, ease of use, and peace of mind. The positioning framework is designed to flex to other segments later without requiring a rebrand.

We build the sales process and enablement materials for your team to execute. For institutional sales, this includes pitch decks tailored to different stakeholders (clinical champions, IT, finance, operations), ROI calculators, compliance documentation checklists, and reference management. For consumer sales, this includes website optimization, ad creative, email sequences, and partner channel development.

Winston Francois brings GTM operating experience across health and consumer technology verticals. We've helped companies navigate the same multi-segment complexity that eldertech presents, and we know how to sequence the GTM to build momentum rather than spreading resources too thin.

What we deliver

Segment prioritization analysis — data-driven decision on which buyer segment to lead with
GTM strategy for lead segment — complete playbook with channels, messaging, and sales process
Positioning framework — flexible enough to serve all segments while leading with one
Sales enablement toolkit — segment-specific pitch materials, ROI tools, and compliance checklists
90-day launch plan with specific targets, milestones, and resource requirements

The biggest GTM mistake in eldertech is treating consumer and institutional sales as either/or. The most successful companies use institutional partnerships as the distribution channel for consumer adoption — health systems deploy the product to their patient populations, solving both the acquisition cost problem and the trust problem simultaneously.

Our Methodology

Our 90-day GTM sprint for eldertech starts with 30 days of analysis. We assess each buyer segment's attractiveness — market size, acquisition cost, sales cycle length, competitive intensity, and your current traction. We interview existing customers, analyze pipeline data, and evaluate your product's readiness for each segment. The output is a segment prioritization recommendation backed by data.

Days 30-60 focus on building the GTM infrastructure for the lead segment. We create the positioning and messaging, design the sales process, build enablement materials, and identify the channels and partners needed for execution. For institutional-led strategies, this includes designing the pilot program structure and building the enterprise sales toolkit.

Days 60-90 are launch and validation. We activate the GTM plan, support your sales team through initial opportunities, and measure early results against targets. Weekly reviews track progress and identify needed adjustments. The goal is a functioning GTM motion that's generating qualified pipeline by day 90.

How We Work

The first 30 days require deep access to your business — CRM data, pipeline history, customer interviews, financial data, and product roadmap. We conduct 8-12 stakeholder and customer interviews alongside quantitative analysis. The segment prioritization recommendation is presented to your leadership team by day 30.

Days 30-60 are collaborative build phase. We work alongside your team to create the GTM toolkit, design processes, and prepare for launch. This phase involves 2-3 working sessions with leadership and weekly production sprints.

Days 60-90 are launch support. We coach your sales team on the new process, support initial customer conversations, and establish the measurement framework. Monthly reviews provide executive-level visibility into GTM performance.

GTM engagements typically run 4-6 months, with the initial sprint establishing the foundation and subsequent months optimizing based on market data. The most successful engagements have direct CEO involvement throughout — GTM strategy in eldertech requires cross-functional alignment between product, clinical, sales, and marketing.

Clear segment prioritization with supporting data
Repeatable sales process for lead buyer segment
Institutional sales readiness (if applicable)
Pipeline generation from focused GTM execution

If your eldertech / agetech company needs go-to-market leadership, we should talk.

Expand your marketing team output with our experts

Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.

Frequently asked questions

How much does a go-to-market strategy cost for an eldertech company?

The initial 90-day GTM sprint typically costs $25K-$50K, including segment analysis, strategy development, sales enablement, and launch support. Ongoing execution support runs $15K-$25K per month. The investment is justified by avoiding the common eldertech trap of spending 12-18 months and hundreds of thousands of dollars trying to serve every segment before finding product-market fit in any of them.

Should our eldertech company start with consumer, caregiver, or institutional sales?

It depends on your product, current traction, and unit economics. Consumer-led works when your product has strong word-of-mouth potential and manageable acquisition costs. Institutional-led works when your product has strong outcome data and the sales team to navigate procurement. Caregiver-led works when caregivers are the decision-makers and payers. We analyze your specific situation to make a data-driven recommendation.

How long does it take to build a repeatable GTM motion in eldertech?

Expect 4-6 months to establish a functioning GTM motion in your lead segment, and 12-18 months before it's truly repeatable with predictable unit economics. The timeline is longer than typical SaaS because the eldertech category requires more buyer education and institutional sales cycles are inherently long. Our 90-day sprint gets the foundation in place and validates the approach.

How do you handle the multi-stakeholder complexity in eldertech sales?

We map the buying committee for each segment and build messaging and materials for each stakeholder. In institutional sales, this might mean separate pitch tracks for clinical champions, IT security, finance, and operations. In consumer sales, it means messaging for both the end user and the family caregiver who influences or funds the purchase. The GTM strategy accounts for all stakeholders, not just the primary buyer.

What makes Winston Francois different for eldertech GTM?

We've built GTM strategies for companies facing the same multi-segment complexity — health tech products sold to consumers, caregivers, and institutions simultaneously. We know how to sequence segments, build cross-segment positioning, and avoid the trap of trying to serve everyone at once. We bring operator experience, not just consulting frameworks.

What size eldertech company is the right fit for GTM strategy work?

Companies with a working product and some early customers — typically $500K-$20M in revenue. If you're pre-product, you need product development support, not GTM strategy. If you're above $30M, you likely have enough data to build GTM internally with targeted specialist support. The sweet spot is post-product, pre-scale companies that need to find the repeatable growth path.